Manufacturing / Biological Products, Except Diagnostic Substances
Outlook Therapeutics, Inc.
OTLK
$0.57
+$0.01 (+1.06%)
Price as of Oct 9, 2026 16:40 UTC
150 M
Market Cap (Micro Cap)
Dec 17
Next Earnings
Technical Signals
as of Oct 7
Bearish
0 of 7
Trend
- Above 20-day average $0.63
- Above 50-day average $0.74
- Above 200-day average $0.86 · -31.6%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) Down · 24d ago
- Momentum cross (20/50) Down · 37d ago
Volume
- Below-average volume 1.0x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for OTLK options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
15 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Sep 01, 2026 | Lundquist Kevin Michael | Grant | 500,000 | $0 | -9.7% | |
| Aug 14, 2026 | Jahr Robert Charles | Buy | 151,515 | $0 | -26.3% | |
| Aug 14, 2026 | Jahr Robert Charles | Buy | 151,515 | $0 | -26.3% | |
| Aug 14, 2026 | KENYON LAWRENCE A | Buy | 101,010 | $0 | -26.3% | |
| Aug 14, 2026 | KENYON LAWRENCE A | Buy | 101,010 | $0 | -26.3% | |
| Aug 12, 2026 | Sukhtian Ghiath M. | Buy | 2,525,252 | $2,499,999 | -43.4% | |
| Aug 12, 2026 | Sukhtian Ghiath M. | Buy | 2,525,252 | $0 | -49.1% | |
| Jul 29, 2026 | Sukhtian Faisal Ghiath | Buy | 95,398 | $99,996 | -46.6% | |
| Jul 21, 2026 | Jahr Robert Charles | Grant | 100,000 | $0 | -60.6% | |
| Jul 21, 2026 | KENYON LAWRENCE A | Grant | 210,078 | $0 | -60.6% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 14, 2026 | Q3 2026 | -$0.10 | |||
| Aug 12, 2026 | Q3 2026 | -$0.10 | |||
| Jun 30, 2026 | Q3 2026 | -$0.10 | -$0.09 | +5.5% | Beat |
| Mar 31, 2026 | Q2 2026 | -$0.12 | -$0.16 | -30.7% | Miss |
| Dec 31, 2025 | Q1 2026 | -$0.18 | -$0.22 | -24.4% | Miss |
| Sep 30, 2025 | Q4 2025 | -$0.26 | -$0.19 | +26.5% | Beat |
Track OTLK with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for OTLK and your entire portfolio.